| AC IMMUNE SA SF-,02 |
| Schweiz |
| Gesundheit |
| CH0329023102 / A2AR5F |
| IMR (Frankfurt) / ACIU (NASDAQ) |
| FRA:IMR, ETR:IMR, IMR:GR, NASDAQ:ACIU |
| - |
| https://www.acimmune.com/ |
|
AC Immune SA is a clinical-stage biopharmaceutical company focused on precision medicine for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and NeuroOrphan indications driven by misfolded proteins. The company des..
>Volltext.. |
| 207.8 Mio. EUR |
| 132.12 Mio. EUR |
| 3.98 Mio. EUR |
| - |
| -71.21 Mio. EUR |
| -0.72 EUR |
| 4.63 Mio. EUR |
| 20.64 Mio. EUR |
| - |
| 0.81 |
| -86.76% |
| -32.92% |
| - |
| - |
| - |
| - |
| AC IMMUNE |
| 11.08.26 |
|